Monsanto Co. (MON) Rating Reiterated by BMO Capital Markets
Monsanto Co. (NYSE:MON)‘s stock had its “outperform” rating reaffirmed by investment analysts at BMO Capital Markets in a research note issued to investors on Saturday. They currently have a $128.00 price target on the stock. BMO Capital Markets’ price objective points to a potential upside of 23.84% from the company’s current price.
Other equities analysts have also issued research reports about the company. Piper Jaffray Cos. reiterated an “overweight” rating and issued a $127.00 price target (up previously from $95.00) on shares of Monsanto in a research report on Monday, June 13th. Zacks Investment Research lowered Monsanto from a “hold” rating to a “strong sell” rating in a research report on Friday. Argus restated a “buy” rating and set a $128.00 price objective (up from $111.00) on shares of Monsanto in a research report on Wednesday, June 15th. Vetr upgraded Monsanto from a “buy” rating to a “strong-buy” rating and set a $122.43 price objective for the company in a research report on Tuesday, August 9th. Finally, Goldman Sachs Group Inc. set a $92.00 price objective on Monsanto and gave the stock a “sell” rating in a research report on Monday, June 27th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company. The stock has an average rating of “Buy” and an average target price of $114.67.
Monsanto (NYSE:MON) opened at 103.36 on Friday. Monsanto has a 12-month low of $83.73 and a 12-month high of $114.26. The stock has a market cap of $45.23 billion, a PE ratio of 45.49 and a beta of 1.19. The firm has a 50-day moving average price of $104.86 and a 200-day moving average price of $101.43.
Monsanto (NYSE:MON) last released its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.02) by $0.09. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The business earned $2.56 billion during the quarter, compared to analyst estimates of $2.38 billion. During the same quarter last year, the company posted ($0.19) EPS. Monsanto’s revenue for the quarter was up 8.8% on a year-over-year basis. Analysts forecast that Monsanto will post $4.89 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be paid a $0.54 dividend. This represents a $2.16 annualized dividend and a yield of 2.09%. The ex-dividend date of this dividend is Wednesday, October 5th. Monsanto’s dividend payout ratio is 71.05%.
In related news, CEO Michael K. Stern sold 12,797 shares of the business’s stock in a transaction on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total value of $1,302,350.69. Following the sale, the chief executive officer now owns 21,583 shares of the company’s stock, valued at approximately $2,196,501.91. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Brett D. Begemann sold 27,980 shares of the business’s stock in a transaction on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total value of $2,899,287.60. Following the completion of the sale, the chief operating officer now directly owns 102,480 shares in the company, valued at approximately $10,618,977.60. The disclosure for this sale can be found here. 0.88% of the stock is owned by corporate insiders.
A number of hedge funds have recently made changes to their positions in the stock. Mycio Wealth Partners LLC raised its stake in shares of Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock valued at $113,000 after buying an additional 12 shares in the last quarter. Moody National Bank Trust Division raised its stake in shares of Monsanto by 0.3% in the second quarter. Moody National Bank Trust Division now owns 4,883 shares of the company’s stock valued at $505,000 after buying an additional 15 shares in the last quarter. Quadrant Capital Group LLC raised its stake in shares of Monsanto by 0.9% in the second quarter. Quadrant Capital Group LLC now owns 1,858 shares of the company’s stock valued at $184,000 after buying an additional 16 shares in the last quarter. Advisor Partners LLC raised its stake in shares of Monsanto by 0.4% in the second quarter. Advisor Partners LLC now owns 6,238 shares of the company’s stock valued at $645,000 after buying an additional 23 shares in the last quarter. Finally, Trust Co. of Vermont raised its stake in shares of Monsanto by 0.6% in the second quarter. Trust Co. of Vermont now owns 4,932 shares of the company’s stock valued at $510,000 after buying an additional 30 shares in the last quarter. 79.02% of the stock is currently owned by institutional investors and hedge funds.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.